M&A in a Changing European Landscape: Can the Boom Survive Brexit?

he UK’s impending and uncertain split from the European Union and ongoing international trade tensions are doing little to dampen enthusiasm for M&A.

Read More

Prominent Derivatives Lawyer Joyce Xu Joins Paul Hastings in New York

Joyce Xu, a prominent derivatives lawyer, has joined the firm as a partner in the Securities and Capital Markets practice.

Learn More

Acrotech Biopharma to Acquire Hematology/Oncology Portfolio

The firm represented Spectrum Pharmaceuticals, Inc. in its pending sale of seven FDA-approved hematology/oncology products to Acrotech Biopharma LLC.

Learn More

Yuzhou Properties Issues Two Senior Notes with Combined Value of US$1B

We represented Yuzhou Properties Company Limited, a leading PRC property developer listed on the Hong Kong Stock Exchange, on two transactions involving issuances of senior notes.

Learn More

on The American Lawyer’s A-List of the most successful firms eight years in a row


in the Financial Times’ Innovative Lawyers Report across Asia, Europe, and North America


for “Overall Best Law Firm to Work For” in Vault’s annual survey six years in a row


for Best Overall Diversity, according to Vault and MCCA

More About Us